Evidence map›Paper›PMID 28452488›Full record

ArticleJournal of proteome research2017

Metabolomics Study of the Effects of Inflammation, Hypoxia, and High Glucose on Isolated Human Pancreatic Islets.

Marta Garcia-Contreras, Alejandro Tamayo-Garcia, Kirk L Pappan, Gregory A Michelotti, Cherie L Stabler, Camillo Ricordi, Peter Buchwald

Open access · greenAbstract read
In one paragraph

Article in Journal of proteome research, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
5.0field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 56 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Review
  11. Review
  12. Article
  13. Article
  14. Review
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. DCyFIR: a high-throughput CRISPR platform for multiplexed G protein-coupled receptor profiling and ligand discovery.Proceedings of the National Academy of Sciences of the United States of America · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 3 countries.

Marta Garcia-ContrerasDiabetes Research Institute, Miller School of Medicine, University of Miami , Miami, Florida 33136, United States.
Alejandro Tamayo-GarciaDiabetes Research Institute, Miller School of Medicine, University of Miami , Miami, Florida 33136, United States.
Kirk L PappanMetabolon, Inc. , Durham, North Carolina 27713, United States.
Gregory A MichelottiMetabolon, Inc. , Durham, North Carolina 27713, United States.
Cherie L StablerDepartment of Biomedical Engineering, University of Florida , Gainesville 32611, Florida, United States.ORCID 0000-0003-0573-0646
Camillo RicordiDiabetes Research Institute, Miller School of Medicine, University of Miami , Miami, Florida 33136, United States.
Peter BuchwaldDiabetes Research Institute, Miller School of Medicine, University of Miami , Miami, Florida 33136, United States.ORCID 0000-0003-2732-8180
University of Miami · USMetabolon (United States) · USUniversity of Florida · US

Funding

Engineering a Human Physiomimetic Islet MicrosystemUC4DK104208 · NIDDK · UNIVERSITY OF FLORIDA · PI AGARWAL, ASHUTOSH, RICORDI, CAMILLO · 2014 to 2014
$4.9M
A comprehensive liquid biopsy platform for detection and prognostication in early stage breast cancerU01CA233363 · NCI · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI AGARWAL, ASHUTOSH, COTE, RICHARD JAMES · 2018 to 2022
$2.6M
NCI NIH HHS U01 CA233363NIDDK NIH HHS UC4 DK104208
6 · The paper itself

Abstract

The transplantation of human pancreatic islets is a therapeutic possibility for a subset of type 1 diabetic patients who experience severe hypoglycemia. Pre- and post-transplantation loss in islet viability and function, however, is a major efficacy-limiting impediment. To investigate the effects of inflammation and hypoxia, the main obstacles hampering the survival and function of isolated, cultured, and transplanted islets, we conducted a comprehensive metabolomics evaluation of human islets in parallel with dynamic glucose-stimulated insulin release (GSIR) perifusion studies for functional evaluation. Metabolomics profiling of media and cell samples identified a total of 241 and 361 biochemicals, respectively. Metabolites that were altered in highly significant manner in both included, for example, kynurenine, kynurenate, citrulline, and mannitol/sorbitol under inflammation (all elevated) plus lactate (elevated) and N-formylmethionine (depressed) for hypoxia. Dynamic GSIR experiments, which capture both first- and second-phase insulin release, found severely depressed insulin-secretion under hypoxia, whereas elevated baseline and stimulated insulin-secretion was measured for islet exposed to the inflammatory cytokine cocktail (IL-1β, IFN-γ, and TNF-α). Because of the uniquely large changes observed in kynurenine and kynurenate, they might serve as potential biomarkers of islet inflammation, and indoleamine-2,3-dioxygenase on the corresponding pathway could be a worthwhile therapeutic target to dampen inflammatory effects.

Indexed as

HyperglycemiaHypoxiaInflammationBiomarkersHumansInsulinInsulin SecretionIslets of LangerhansIslets of Langerhans TransplantationKynurenic AcidKynurenineMetabolomicsBiomarkersInsulinKynurenic AcidKynureninecytokineshuman isletshyperglycemiahypoxiainsulin secretionmetabolomicsperifusion

Identifiers

PMID28452488
PMCPMC5557342
OpenAlexW2608974576

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.